Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
Holders of 5% or more of BXRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Baudax Bio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Baudax Bio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Baudax Bio, Inc., newest first.
No Schedule 13D or 13G filings on Baudax Bio, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Baudax Bio, Inc. shares.
No Form 144 notices for Baudax Bio, Inc. are on file.